IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Akums Drugs and Pharmaceuticals IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1856.74 Cr. The company is based in New Delhi and caters to Pharmaceutical sector. Ambit , Axis Bank , Citigroup Global Markets India , ICICI Securities are the merchant bankers of Akums Drugs and Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th February 2024.
Akums Drugs and Pharmaceuticals IPO posted revenues of ₹ 4212.21 crores and PAT of ₹ 0.79 crores in FY25 on annualised basis.
Revenue:
₹ 4,178.18 Cr.
EBITDA Margin:
3.76
% 
Net Worth: ₹ 720.49 Cr.
Market Capitalisation:
[●]
P/E:
29.79 times
P/BV: [●]
EV/EBITDA: 2.42 times
Financial results of Akums Drugs and Pharmaceuticals IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY24 | FY23 | FY22 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 1940.78 | 1878.87 | 1864.06 | ||
| Net Worth | 720.49 | 723.37 | 625.17 | ||
| Total Debt | 491.56 | 536.97 | 357.95 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
4178.18 | 3654.82 | 3671.89 | ||
EBITDA
EBITDA on annualised basis |
157.01 | 384.06 | -69.09 | ||
PAT
PAT on annualised basis |
0.79 | 97.82 | -250.87 | ||
Akums Drugs and Pharmaceuticals IPO PAT Margin is 0.02 % , ROCE (Return on Capital Employed) is 3.37 % as per latest financial. The below table shows Akums Drugs and Pharmaceuticals IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY24 | FY23 | FY22 |
|---|---|---|---|
| EBITDA Margin (%) | 3.76 | 10.51 | -1.88 |
| PAT Margin (%) | 0.02 | 2.68 | -6.83 |
| EPS (₹) | -0.28 | 6.63 | -17.65 |
| ROE (%) | 0.11 | 13.52 | -40.13 |
| ROCE (%) | 3.37 | 24.60 | -18.89 |
| ROA (%) | 0.04 | 5.21 | -13.46 |
| Debt to Equity | 0.68 | 0.74 | 0.57 |
The market Capitalisation of Akums Drugs and Pharmaceuticals IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Akums Drugs and Pharmaceuticals IPO prospectus highlights an Return on Equity (ROE) of 0.11 % , Return on Assets (ROA) of 0.04 %, and an EBITDA Margin of 3.76 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Akums Drugs and Pharmaceuticals IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Akums Drugs and Pharmaceuticals IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Akums Drugs and Pharmaceuticals IPO has a Price-to-Earnings (PE) ratio of 29.79 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Akums Drugs and Pharmaceuticals IPO reported revenue of ₹ 4212.21 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Akums Drugs and Pharmaceuticals IPO provide insights into sales growth, market demand, and business scalability.
Akums Drugs and Pharmaceuticals recorded an EBITDA of ₹ 157.01 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Akums Drugs and Pharmaceuticals Profit After Tax (PAT) is ₹ 0.79 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 4,178.18 Cr.
EBITDA Margin:
3.76
%
Net Worth: ₹ 720.49 Cr.
Market Capitalisation:
[●]
P/E:
29.79 times
P/BV: [●]
EV/EBITDA: 2.42 times
Akums Drugs and Pharmaceuticals operates in Pharmaceutical and Pharmaceuticals. The Issue is listed on BSE,NSE in Aug, 2024. Akums Drugs and Pharmaceuticals IPO size was 1856.74 with Issue price of 679.00 .
Merchant Banker(s) of Akums Drugs and Pharmaceuticals IPO: Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited
Akums Drugs and Pharmaceuticals IPO subscription was 63.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Akums Drugs and Pharmaceuticals IPO listed at a listing price of 796.35 against the offer price of 679.00.
The current market price of Akums Drugs and Pharmaceuticals is 582.90.
Why Us?
